Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Exclusion Criteria

• •Either eye with previous or active sub-retinal neovascularization (SRNV) or choroidal neovascularization (CNV)
• •Pigment epithelial detachment (PED) within 500 µm of the fovea
• •Either eye with a diagnosis of exudative (wet) AMD
• •Subjects having undergone cataract surgery less than 3 months prior to enrollment without an open posterior capsule
• •Uncontrolled hypertension and/or diabetes
• •Subjects with prolonged PT/PTT (unless the subject is taking warfarin), hematocrit \<35%, evidence of active bleeding, platelet count \<100,000/ml